Safety and Efficacy of Topical Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Pilot Study.

Roberto Gonzalez-Salinas Elizabeth YeuMark HoldbrookStephanie N BabaJuan Carlos CeballosMartha Massaro-CorredorClaudia Corredor-OrtegaNallely Ramos-BetancourtHugo Quiroz-Mercado

Published in: Journal of ophthalmology (2021)

Topical lotilaner ophthalmic solution, 0.25% for 4 weeks, showed promising efficacy for the treatment of Demodex blepharitis. This novel treatment appears to be safe and well tolerated. Randomized controlled studies are needed to confirm the results.

Keyphrases

combination therapy
double blind
replacement therapy
study protocol
placebo controlled
smoking cessation
gestational age
phase ii